Which trial do we need? Defining the optimal duration of antifungal therapy for invasive pulmonary aspergillosis

Clinical Microbiology and Infection 2026

View at publisher
Authors: Guillaume DESOUBEAUX, Malgorzata Mikulska, Adrien LEMAIGNEN, Emmanuel GYAN, Jannik STEMLER, Yuri Vanbiervliet, Johan MAERTENS, Olivier LORTHOLARY, Olivier Paccoud, Monica A Slavin, Oliver A. CORNELY, Dionysios NEOFYTOS
+1 more Fanny LANTERNIER
DOI: 10.1016/j.cmi.2026.01.030
Cited by: 2
References: 15

Fields of Study & Subjects

Antifungal resistance and susceptibility Infectious Diseases and Mycology Fungal Infections and Studies

Publication details

Journal / source
Clinical Microbiology and Infection
Publisher
Elsevier BV
Volume
32
Issue
5
Pages
683–686
Publication date
7 February 2026
Language
EN